Decision analysis in pediatric cardiology outcomes research

Progress in Pediatric Cardiology

Volumn 7, Issue 2, 1997, Pages 67-75

  Danford, David A ^a  

^a NONE

Author keywords

Congenital heart disease; Cost benefit analysis; Cost effectiveness analysis; Decision analysis; Outcomes; Pediatric cardiology

Indexed keywords

ADOLESCENT; ANALYSIS; ARTICLE; CARDIOLOGY; CHILD; COST BENEFIT ANALYSIS; HEALTH CARE DELIVERY; HEART DISEASE; HUMAN; MANAGEMENT; MATHEMATICAL ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY;

EID: 0030751144     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(97)00010-6     Document Type: Article

References (37)

1. Kassirer JP, Moscovitz AJ, Lau J, Pauker SG. Decision analysis: a progress report. Ann Intern Med. 1987;106: 275-291.
2. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987;316:250-258.
3. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:419-458.
4. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease, part I: general principles. Prog Cardiovasc Dis 1995;37:161-184.
5. Powell C, Moller J. Pediatric cardiology outcomes research using a voluntary generic registry. Prog Pediatr Cardiol 1997 (in press).
6. Lloyd T. Pediatric cardiology outcomes research using an intervention-specific registry: the PDA Coil Registry. Prog Pediatr Cardiol 1997 (in press).
7. Holmes MM, Rovner DR, Rothert MI. Women's vs physicians' utilities for health outcomes in estrogen replacement therapy. J Gen Intern Med 1987;2:178-182.
8. Kaplan SH. Functional outcomes measurement in pediatrics. Prog Pediatr Cardiol 1997 (in press).
9. Pauker SG, Kassirer JP. Clinical decision analysis by personal computer. Arch Intern Med 1981;141:1831-1837.
10. Lau J, Kassirer JP, Pauker SG. DECISION MAKER 3.0: improved decision analysis by personal computer. Med Decis Making 1983;3:39-43.
11. Hollenberg J. SMLTREE: the all-purpose decision tree builder. 2nd ed. Boston: Pratt Medical Group, 1986.
12. LaPuma J, Lawlor EF. Quality-adjusted life-years: ethical implication for physicians and policy makers. J Am Med Assoc 1990;263:2917-2921.
13. Mehrez A, Gafni A. Quality adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making 1989;9:142-149.
14. Froberg DG, Kane RL. Methodology for measuring health-state preferences - II: scaling methods. J Clin Epidemiol 1989;42:459-471.
15. Bailey LL, Gundry SR. Hypoplastic left heart syndrome. Pediatr Clin N Am 1990;37:137-150.
16. Spiegelhalter DJ, Rigby ML. Medical management. In: Anderson RH, Macartney FJ, Shinebourne EA, Tynan M, editors. Paediatric Cardiology. Edinburgh: Churchill Livingstone 1987;429-434.
17. Gray DT, Fyler DC, Walker AM, Weinstein MC, Chalmers TC. Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. N Engl J Med 1993;329:1517-1523.
18. Koplan JP, Preblud SR. A benefit-cost analysis of mumps vaccine. Am J Dis Child 1982;136:362-364.
19. Goldman L, Sia STB, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 1988;319:152-157.
20. Gould IM, Buckingham JK. Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis. Br Heart J 1993;70:79-83.
21. Garson A Jr, Gorry GA, McNamara DG, Cooley DA. The surgical decision in tetralogy of Fallot: weighing risks and benefits with decision analysis. Am J Cardiol 1980;45:108-116.
22. Georgeson S, Coombs AT, Eckman MH. Prophylactic use of the intra-aortic balloon pump in high-risk cardiac patients undergoing noncardiac surgery: a decision analytic view. Am J Med 1992;92:665-678.
23. Bay KS, Flathman D, Nestman L. The worth of a screening program: an application of a statistical decision model for the benefit evaluation of screening projects. Am J Public Health 1976;66:145-150.
24. Fulton MJ, Barer ML. Screening for congenital dislocation of the hip: an economic appraisal. Can Med Assoc J 1984;130:1149-1156.
25. Doubilet P, McNeil BJ, Weinstein MC. The decision concerning coronary angiography in patients with chest pain. Med Decis Making 1985;5:293-309.
26. Berwick DM, Komaroff AL. Cost-effectiveness of lead screening. N Engl J Med 1982;306:1392-1398.
27. Danford DA, Nasir A, Gumbiner C. Cost assessment of the evaluation of heart murmurs in children. Pediatrics 1993;91:365-368.
28. Everett WD. Screening for mitral valve prolapse: an analysis of benefits and costs in the US. Air Force. Aviat Space Environ Med 1989;60:A80-A88.
29. Georgeson S, Meyer KB, Pauker SG. Decision analysis in clinical cardiology: when is coronary angiography required in aortic stenosis. J Am Coll Cardiol 1990;15:751-762.
30. Joffe A, McCormick M, DeAngelis C. Which children with febrile seizures need lumbar puncture? A decision analysis approach. Am J Dis Child 1983;137:1153-1156.
31. Danford DA. Factors influencing choice of procedure in transposition of the great arteries: a decision analysis approach. J Am Coll Cardiol 16:1990;471-475.
32. Larsen GC, Manolis AS, Sonnenberg FA, Beshanski JR, Estes NAM, Pauker SG. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323-1334.
33. Alm J, Larsson A, Rosenqvist U. Health economic analysis of the Swedish neonatal metabolic screening programme: a method of optimizing routines. Med Decis Making 1982;2:33-45.
34. Schoenbaum SC, Hyde JN, Bartoshesky L, Crampton K. Benefit-cost analysis of rubella vaccine policy. N Engl J Med 1976;294:306-310.
35. Tompkins RK, Burnes DC, Cable WI. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention. Ann Intern Med 1977;86:481-492.
36. Centor PM, Witherspoon JM. Treating sore throats in the emergency room: the importance of follow-up in decision making. Med Decis Making 1982;2:463-469.
37. Lezaun R, Brugada P, Smeets J. Cost-benefit analysis of medical vs surgical treatment of symptomatic patients with accessory atrioventricular pathways. Eur Heart J 1989;10:1105-1109.